Edition:
United States

BioScrip Inc (BIOS.O)

BIOS.O on Nasdaq

1.52USD
28 Apr 2017
Change (% chg)

$0.02 (+1.33%)
Prev Close
$1.50
Open
$1.51
Day's High
$1.53
Day's Low
$1.46
Volume
761,305
Avg. Vol
2,253,182
52-wk High
$3.43
52-wk Low
$0.98

Latest Key Developments (Source: Significant Developments)

BioScrip announces CFO transition
Thursday, 20 Apr 2017 09:00am EDT 

April 20 (Reuters) - BioScrip Inc :BioScrip announces CFO transition.BioScrip Inc says appointment of Stephen M. Deitsch to positions of senior Vice President, Chief Financial Officer and treasurer, effective April 24, 2017.BioScrip Inc says Deitsch succeeds Jeffrey Kreger, who stepped down from his roles as senior Vice President, Chief Financial Officer and treasurer.BioScrip Inc says reiterate our 2017 adjusted EBITDA forecast of $45 million to $55 million.  Full Article

Bioscrip Q4 loss per share $0.06
Friday, 3 Mar 2017 07:45am EST 

Bioscrip Inc : Bioscrip reports fourth quarter and full-year 2016 financial results . Q4 revenue $240.1 million versus I/B/E/S view $235.7 million . Q4 loss per share $0.06 . Q4 earnings per share view $-0.08 -- Thomson Reuters I/B/E/S . Bioscrip Inc - on track to achieve full $17.0 million in home solutions synergies by end of 2017 . Bioscrip Inc - expect to achieve an additional $23.0 to $25.0 million in cost reductions by end of 2017 . Bioscrip Inc - by end of 2017 and we expect an incremental $23.0 million to $25.0 million in cost structure improvements during year . Bioscrip Inc sees 2017 revenues in range of $920.0 million to $950.0 million . Sees adjusted EBITDA in range of $45.0 million to $55.0 million for full-year 2017 .FY2017 revenue view $951.7 million -- Thomson Reuters I/B/E/S.  Full Article

Bioscrip files for offering of up to 3.75 mln shares of common stock by the selling stockholder
Tuesday, 11 Oct 2016 06:06am EDT 

Bioscrip Inc :Files for offering of up to 3.75 million shares of common stock by the selling stockholder - sec filing.  Full Article

Bioscrip And Home Solutions enter deal to expedite closing
Friday, 2 Sep 2016 04:05pm EDT 

Press Release : Bioscrip and home solutions enter into amended asset purchase agreement to expedite closing . Co, hs infusion holdings inc further amended terms of their asset purchase agreement dated june 13, 2016 .Amended agreement to eliminate condition to closing that co receive stockholder approval to increase authorized share capital.  Full Article

Bioscrip enters into a tax asset protection plan
Friday, 12 Aug 2016 06:50am EDT 

Bioscrip Inc : Tax asset protection plan to protect company's ability to "utilize its net operating loss carryforwards" which total approximately $275 million . Bioscrip enters into a tax asset protection plan to protect its valuable tax assets . Will distribute to stockholders non-taxable dividend distribution of 1 preferred stock purchase right for each share of common stock of Co .Tax asset protection plan intended to act as "deterrent" to any person acquiring beneficial ownership of 4.9% or more of Co's common stock.  Full Article

North Tide Capital Master reports a passive stake of 7.5 pct in Bioscrip Inc
Monday, 27 Jun 2016 04:08pm EDT 

Bioscrip Inc :North Tide Capital Master LP reports a passive stake of 7.5 percent in Bioscrip Inc as of June 17, 2016 - SEC filing.  Full Article

BioScrip prices 40 mln shares offering at $2.00 per share
Thursday, 16 Jun 2016 10:20pm EDT 

BioScrip Inc : Says offering of 40.0 million common shares priced at $2.00 per share . Says expects to receive approximately $73.38 million in net proceeds from offering after deducting underwriting discounts .BioScrip prices underwritten offering of common stock.  Full Article

BioScrip to acquire Home Solutions
Monday, 13 Jun 2016 06:02am EDT 

BioScrip Inc : Total transaction consideration of $85.0 million . Will acquire substantially all of assets and assume certain liabilities of Home Solutions and its subsidiaries . Deal includes additional contingent consideration in form of restricted stock units . Closing consideration will consist of $80.0 million payable in cash, subject to certain adjustments and $5.0 million in shares . BioScrip inc says upon completion of transaction, Daniel Greenleaf will become chief executive officer of BioScrip . Upon completion of transaction, Daniel Greenleaf will become chief executive officer of BioScrip and join company's board . Rick Smith, director and chief executive officer of BioScrip will become vice chairman of board of directors . Jeffrey Kreger, chief financial officer of BioScrip, will serve as combined company's chief financial officer . BioScrip will continue to be headquartered in Denver, Colorado and plans to maintain branches throughout United States . Transaction is anticipated to be financed through net proceeds from an equity offering . Jefferies LLC is acting as financial advisor to BioScrip . Houlihan Lokey is acting as financial advisor to Home Solutions .BioScrip announces transformative acquisition of Home Solutions that will enhance focus as home infusion leader.  Full Article

Bioscrip announces proposed public offering of common stock
Monday, 13 Jun 2016 06:00am EDT 

Bioscrip Inc : Commenced an underwritten public offering of its common stock .Bioscrip announces proposed public offering of common stock.  Full Article

BioScrip Inc reaffirms FY 2016 EBITDA Guidance
Wednesday, 4 Nov 2015 07:00am EST 

BioScrip Inc:Reaffirms FY 2016 Adjusted EBITDA Guidance of Between $50 Million - $60 Million.  Full Article

More From Around the Web

BRIEF-Bioscrip Q4 loss per share $0.06

* Bioscrip reports fourth quarter and full-year 2016 financial results